Cyclophosphamide (Sandoz Inc.)
Welcome to the PulseAid listing for the Cyclophosphamide drug offered from Sandoz Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc. |
NON-PROPRIETARY NAME: | cyclophosphamide |
SUBSTANCE NAME: | CYCLOPHOSPHAMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
ROUTE: | INTRAVENOUS; ORAL |
DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-10-31 |
END MARKETING DATE: | 0000-00-00 |
Cyclophosphamide HUMAN PRESCRIPTION DRUG Details:
Item Description | Cyclophosphamide from Sandoz Inc. |
LABELER NAME: | Sandoz Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/25mL) |
START MARKETING DATE: | 2014-10-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-3233_428ac6d9-f555-1adc-e054-00144ff8d46c |
PRODUCT NDC: | 0781-3233 |
APPLICATION NUMBER: | ANDA204555 |
Other CYCLOPHOSPHAMIDE Pharmaceutical Manufacturers / Labelers: